Apellis lands as much as $250M in financing from drug development company
February 28, 2019 at 14:26 PM EST
Apellis Pharmaceutical's newest deal will support clinical development for rare blood disorders.
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart Quotes delayed at least 20 minutes. By accessing this page, you agree to the following Privacy Policy and Terms and Conditions. |
|